Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyperHAES vs mannitol for elevated intracranial pressure after brain injury
2005-005319-66Phase 4Terminated
- Sponsor
- NHS Lothian Research and Development
- Start
- Apr 2006
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of HyperHAES and Bronchitol in intracranial hypertension (IH) and traumatic brain injury (TBI) (2 arms), sponsored by NHS Lothian Research and Development. Primary endpoint: Intracranial pressure reduction below 20 mmHg. Started Apr 2006; status: terminated.
02
Drugs
HyperHAESBronchitol
03
Conditions
intracranial hypertension (IH)traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2005-005319-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005319-66.